ZURA - Zura Bio Limited
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$20.00
DETAILS
HIGH:
$20.00
LOW:
$20.00
MEDIAN:
$20.00
CONSENSUS:
$20.00
UPSIDE:
473.07%
About Zura Bio Limited (https://zurabio.com)
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Kimberly Ann Davis | Chief Operating Officer, Chief Legal Officer & Corporate Secretary | 1968 | $807,203 USD |
| Kiran Nistala MBBS | Chief Medical Officer & Head of Development | 1973 | $691,153 USD |
| Sandeep Chidambar Kulkarni | Co-Founder, CEO & Director | 1981 | $55,550 USD |
| Gary Whale | Chief Technology Officer | 1974 | – |
| Marlyn Mathew | VP of Finance & Accounting and Principal Financial & Accounting Officer | 1984 | – |
| Muzammil Mustufa | Chief Business Officer | – | – |
| Theresa Lowry | Chief Human Resources Officer | 1974 | – |